Anti-angiogenic drug discovery: lessons from the past and thoughts for the future
Author:
Publisher
Informa UK Limited
Subject
Drug Discovery
Link
http://www.tandfonline.com/doi/pdf/10.1517/17460441.2012.695774
Reference181 articles.
1. Tumor Angiogenesis: Therapeutic Implications
2. TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION
3. Hallmarks of Cancer: The Next Generation
4. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents
5. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Non-viral nitric oxide-based gene therapy improves perfusion and liposomal doxorubicin sonopermeation in neuroblastoma models;Theranostics;2023
2. Rejuvenated Stem/Progenitor Cells for Cartilage Repair Using the Pluripotent Stem Cell Technology;Bioengineering;2021-04-10
3. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch;Molecular Cancer Therapeutics;2020-05-05
4. Monitoring of tumor vascular normalization: the key points from basic research to clinical application;Cancer Management and Research;2018-10
5. Delivery of bevacizumab to atheromatous porcine carotid tissue using echogenic liposomes;Drug Delivery;2016-09-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3